6-K ·Filed Apr 17, 2026
Notable filing: 6-K
Actionable Insight • Neutral
No immediate trading implications. This is a routine administrative filing. Traders should focus on upcoming financial results or clinical trial data for material updates.
Final — all horizons settled through T+60d ⚠ clustered
GNMSF ▲ +1.46% at T+60d
NEUTRAL call +1.46% · α vs SPY -4.69% · entry $281.75 → $285.85
T+1d
0.00%
call 0.00% · α +0.19%
$281.75
settled 6mo ago
T+5d
-3.52%
call -3.52% · α -4.08%
$271.83
settled 6mo ago
T+20d
-5.85%
call -5.85% · α -11.22%
$265.27
settled 6mo ago
T+60d
+1.46%
call +1.46% · α -4.69%
$285.85
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
Genmab AS filed an updated version of its Articles of Association, incorporating amendments made on March 19, 2026, including the issuance of warrants to employees and updates to capital authorization. This is a routine corporate update.
Key Facts
- Filing is an updated English translation of Genmab's Articles of Association, effective March 19, 2026.
- The document incorporates historical warrant issuances and authorizations, including a grant of 4,485 shares on March 19, 2026.
- No new material agreements, financial results, or executive changes are announced.
- This is a standard 6-K filing to provide updated corporate governance documents to the SEC.
Financial Impact
None disclosed. The filing is a procedural update of existing articles and historical warrant grants.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000065 |
| Document: gmab_2026417x6k.htm | 0001434265-26-000065 |
| Document: 0001434265-26-000065-index-headers.html | 0001434265-26-000065 |
| Document: 0001434265-26-000065-index.html | 0001434265-26-000065 |
| Document: 0001434265-26-000065.txt | 0001434265-26-000065 |
10 reports for GNMSF
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
May 29, 2026 21w ago | 6-K | $251.55 $262.00 | ▲ +4.15% | ▲ +5.45% | $447.55 (+77.92%) |
May 13, 2026 23w ago | 6-K | $268.24 $249.00 | ▼ −7.17% | ▼ −6.56% | $447.55 (+66.85%) |
May 12, 2026 24w ago | 6-K | $264.64 $249.00 | ▼ −5.91% | ▼ −4.18% | $447.55 (+69.12%) |
May 8, 2026 24w ago | 6-K | $259.60 $249.00 | ▼ −4.08% | ▼ −3.78% | $447.55 (+72.40%) |
Apr 17, 2026 27w ago | 6-K | $281.75 $265.27 | ▼ −5.85% | ▼ −11.22% | $447.55 (+58.85%) |
Apr 17, 2026 27w ago | 6-K | $281.75 $265.27 | ▼ −5.85% | ▼ −11.22% | $447.55 (+58.85%) |
Apr 14, 2026 28w ago | 6-K | $273.25 $259.60 | ▼ −5.00% | ▼ −11.29% | $447.55 (+63.79%) |
Apr 1, 2026 29w ago | 6-K | $265.00 $255.25 | ▼ −3.68% | ▼ −13.40% | $447.55 (+68.89%) |
Apr 1, 2026 29w ago | 6-K | $265.00 $255.25 | ▼ −3.68% | ▼ −13.40% | $447.55 (+68.89%) |
Mar 30, 2026 30w ago | 6-K | $265.00 $255.25 | ▼ −3.68% | ▼ −13.10% | $447.55 (+68.89%) |
Showing 10 of 10
US Market Status
Market Open — Closes in 1h 53m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers